DealElephas Biosciences, a Madison, WI-based live tumor profiling platform, raised $40 million in a Series B-2 fundraising round led by Northpond Ventures with participation from ARCH Venture Partners and State of Wisconsin Investment Board.
More on VC News Daily →
SERIES B
11/08/2025
Mevo, a São Paulo-based consumer internet platform, raised $18 million in...
Centivax, Inc., a San Francisco-based universal vaccines developer, raised...
Audicin, a Finland-based real-time nervous system tech company, raised...
Cara, a New York-based AI platform for insurance, raised $8 million in a...
WHOOP, a Boston-based fitness-tracking wristband maker, raised $575...
Wearable Robotics, a Pisa, Italy-based developer of wearable exoskeletons,...
Stay informed on industry shifts, deal trends, and career opportunities in venture capital.
